All News

Questions this month have been answered by:Barry Lee Gruber, MD OBGYN.net Editorial Advisor Maria Luisa Bianchi, MD, OBGYN.net Osteoporosis Editorial Advisor

The latest in medical products for obstetrics and gynecology.

If the message is you don't need a Pap smear, many patients will hear: you don't need a visit.

Last year, the CDC released updated recommendations for the treatment of STIs. Here are several highlights from the new guidelines.

To most accurately detect abnormalities, all chromosomes have to be evaluated. And the day is not far off when our best hope for doing so-comparative genomic hybridization (CGH)-microarrays for PGD-will be widely available.

Evidence for the "stress test" theory suggests that women with a history of preeclampsia, spontaneous abortion, preterm delivery, or delivery of a low birthweight infant are at increased risk for future disease. Knowing this in advance could allow physicians to address the problems women may face early enough so that they can still benefit from lifestyle and pharmacologic interventions.

One out of five teens and adults has genital herpes-many of them women. How can you help stem the epidemic? By identifying patients at risk for acquiring and transmitting herpes simplex virus using type-specific serologic tests, say these experts.

One out of five teens and adults has genital herpes-many of them women. How can you help stem the epidemic? By identifying patients at risk for acquiring and transmitting herpes simplex virus using type-specific serologic tests, say these experts.

Although the drug is not indicated as first-line therapy in ob/gyn patients, research suggests it may sometimes prove lifesaving during gynecologic surgery and in women experiencing postpartum hemorrhage.

When diagnostic films, labs, and pathology are unavailable or inconclusive, a physician certainly has the right to rely upon his or her clinical evaluation in rendering a differential diagnosis and recommending treatment. But when physicians make a decision not to use such diagnostic tools-particularly for economic reasons-the clinical evaluation they choose to rely upon had best be eminently reasonable, if not entirely accurate.

Encourage pregnant patients to have necessary dental work done, but avoid tetracyclines.

I must admit I was very skeptical when I first heard that the NICHD Maternal-Fetal Medicine Units Network was going to conduct a randomized clinical trial of 17-hydroxyprogesterone caproate for the prevention of prematurity. . .

This month's questions answered by:Harvey S. Marchbein, MD,Chairman, Editorial Advisory Board,Osteoporosis Section, OBGYN.netRonald Barentsen, MD, PhD,Member, Editorial Advisory Board,Osteoporosis Section, OBGYN.net

Clinical situations that typically result in litigation and the variation in jury verdicts and awards across the nation.

At some point you may need to consider merging the practice into a hospital or larger group. Like all processses of growth, merging medical practices can involve risk and a certain amount of pain. Here's how to prepare yourself for the transition.

Think of this legal expert's advice as your personal GPS for deftly navigating a maze of employment law challenges and preventing costly litigation.

To preserve or enhance your income, you need to master the local medical marketplace.

Questions this month have been answered by:Paul D. Burstein, MD, FACOG, USA, OBGYN.net Osteoporosis Editorial AdvisorMichael Kleerekoper, MB, BS, FACP, FACE, OBGYN.net Editorial Advisor

SMFM 27th Annual Meeting 2007

SMFM 27th Annual Meeting 2007

SMFM 27th Annual Meeting 2007

SMFM 27th Annual Meeting 2007

SMFM 27th Annual Meeting 2007

SMFM 27th Annual Meeting 2007

Only one in five women between the ages of 18 and 44 know their cholesterol level, despite the fact that cholesterol is a major risk factor for heart disease, the number one killer of women in the United States.

SMFM 27th Annual Meeting 2007

SMFM 27th Annual Meeting 2007

SMFM 27th Annual Meeting 2007